Cre8 Evo

Sirolimus eluting balloon expandable coronary stent

Advantages:

• The only polymer-free technology able to precisely control abluminal drug elution

• Fatty Acids enhance drug distribution and maximize drug bioavailability increasing device efficacy, particularly in diabetic patients

• New stent architecture designed for effective drug concentration, including complex coronary anatomies and pathologies like those of diabetic patients

• Proven hemo/biocompatibility versus lumen blood flow and faster strut coverage